Razvan Alexandru Radu

TL;DR: COVID-19 is associated with a small but significant risk of clinically relevant cerebrovascular events, particularly ischemic stroke, and aggressive monitoring and early intervention should be pursued to mitigate poor outcomes.

TL;DR: An ideal ischemic stroke classification should both comprise all underlying pathologies that could potentially concur to an index event and emphasize the most likely etiological and pathophysiological mechanism.

TL;DR: In this paper, the authors reviewed all published cases of CVST in patients with COVID-19 infection from January 1, 2020 to November 13, 2020 and evaluated their clinical presentations, risk factors, clinical management, and outcome.

TL;DR: In this article , the authors evaluated the safety and outcomes of revascularization treatments in patients with acute ischemic stroke (AIS) and COVID-19 and found that patients with COVID19 had higher rates of intracranial bleeding complications and worse clinical outcomes than contemporaneous non-COVID19 patients receiving treatment.

TL;DR: The case of a 75-year-old woman who was admitted in the authors' department in early fall for altered mental status, opsoclonus, multifocal myoclonuses, truncal titubation and generalized tremor, preceded by a 5 day prodrome consisting of malaise, nausea, fever and vomiting is reported.